$IMMB .213 Immunotech Relocates to New Research

New Post Public Reply Private Reply Replies (1) Message Board
jstops

[b]$IMMB[/b] .213 Immunotech Relocates to New Research & Development Laboratory Facility


PASADENA, CA, [b][color=blue]Mar 01, 2013[/color][/b] (MARKETWIRE via COMTEX) -- Immunotech Laboratories, Inc. (PINKSHEETS: IMMB) today announced the company has relocated to a new Research & Development Lab facility in Monrovia, California.

The new facility incorporates more laboratory use of the actual facility than the combined Administrative space at the previous Pasadena location. The new location also is geographically more conveniently located for the Immunotech team.


In light of the recent announcements stating the HIV-AIDS and Hepatitis C clinical trials using the company's patented "ITV-1" patented technology treatment by the Immunotech BG sister company, more clinical research and results testing is necessary. The new facility accommodates the additional lab space.


Utilizing a combination of the clinical tests and results being conducted in Bulgaria alongside the results analysis here in the USA at the new facility, Immunotech plans to submit all the results from the Bulgarian clinical trials for US Food & Drug Administration "FDA" approval on a pre IND meeting. Immunotech Laboratories plans to start working with IND Directions, LLC (http://inddirections.com)


Immunotech's ultimate goal is to provide a worldwide FDA approved treatment for combating the HIV-AIDS virus with the intent of terminating the virus and restoring the immune system. The goal of this treatment is to achieve reduction of resistance of existing therapies on the market.


The clinical trials in Bulgaria (Referred to as EU) are scheduled to begin in May 2013 and end in October 2013, which will give Immunotech, the rights to receive approval for applications of the "IPF" Treatment. In this respect, Immunotech Laboratories BG has had a series of conversations with Mr. Vladimir Stoichev, the Deputy General Director from Sopharma Bulgaria, and the parties have had talks for the possible signing of a contract between Immunotech Laboratories BG and Sopharma for joint production of IPF-ITV.


Sopharma is a leading pharmaceutical company in the European Union.


RELEVANT ARTICLES & LINKS FOR AIDS-HIV MEDICINES


http://news.yahoo.com/gsk-wins-priority-statu...nance.html


About Immunotech Laboratories Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases such as HIV, Cancer, Hepatitis and Aids. www.immunotechlab.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trade Cases on Pizza Box Imports Set Industry Ablaze

Updated Category News Views 66

U.S. Takes Stand Against Unfair Import Practices Who knew pizza boxes could stir up such a fuss, huh? Well, here we are. The U.S. International Trade Commission (ITC) has sided with American pizza box manufacturers, waving the flag against those sneaky imports from China, Malaysia, and Turkey. According to the ITC, these imports are causing some real headaches for the...

Continue Reading
Duolingo Investors Must Weigh Legal Options Now

Updated Category News Views 101

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Continue Reading
ScienceOra Unveils AI Catalyst Design at Tencent Summit

Updated Category News Views 54

AI in Material Science: Beyond Buzzwords There's a lot of talk out there about AI changing the world, but it's always a different tune when it's put under a microscope. At the 2026 Tencent Global Digital Ecosystem Summit, ScienceOra and Wenge AI showcased an AI-assisted workflow for designing hydrogen-production catalysts. This isn't your average AI cheerleading session,...

Continue Reading
Investigation of Maplebear Sale to DoorDash Sparks Debate

Updated Category News Views 174

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

Continue Reading
Aurora Innovation Faces Supply Chain Hurdles & Legal Scrutiny

Updated Category News Views 88

Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...

Continue Reading
Orbis International to Boost Global Eye Health Efforts

Updated Category News Views 113

Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...

Continue Reading
Twilio's SEC Investigation: Legal Impacts on Investors

Updated Category News Views 54

Twilio's Legal Troubles: Investors Take Notice Twilio's facing a firestorm, folks. After guiding its organic revenue growth down a few notches, the company saw its shares plummet 17%. Now, they're under the microscope for possibly not playing it straight with their growth numbers, and that’s never a good look with Uncle Sam watching. Folks at Levi & Korsinsky are on the...

Continue Reading
Neuberger Fund Ups Distribution Amid Market Challenges

Updated Category News Views 70

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Continue Reading
Karma Automotive Debuts High-Stakes Eximius Program

Updated Category News Views 0

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

Continue Reading
WesternU's Big Night: Boosting Lebanon’s Health Hub

Updated Category News Views 64

Building Bridges in Healthcare: WesternU's Strategic Move Heck, you know it's the real deal when a university throws a dinner party to celebrate partnerships. Western University of Health Sciences (WesternU) decided to clink glasses with Lebanon community leaders, hammering home the importance of their collaboration on October 6, 2026. Now, don't think this was just some...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Faces Scrutiny Over Financial Disclosures

Updated Category News Views 384

America's Car-Mart Under Investor Scrutiny Recently, America's Car-Mart, Inc. (NASDAQ: CRMT) experienced a noteworthy stock decline as investors reacted to disappointing Q1 2026 financial results. The significant drop of over $8, approximately 18%, raised concerns among shareholders and prompted investigation into the company's operational strategies concerning tariff...

Continue Reading
Lands' End Reports Positive Financial Growth for Fiscal Year 2024

Updated Category News Views 210

Lands' End Achieves Significant Financial Milestones DODGEVILLE, Wis. – Lands’ End, Inc. (NASDAQ: LE) has announced its financial results for the fourth quarter and the entire fiscal year 2024, which concluded recently. This announcement follows a year characterized by steady growth and strategic innovation. Strong Performance in the Fourth Quarter During the fourth...

Continue Reading
Novo Nordisk's Wegovy® Shows Promise for Liver Health in MASH

Updated Category News Views 217

Wegovy® Demonstrates Hepatic Benefits Beyond Weight Loss Novo Nordisk has recently unveiled intriguing findings regarding Wegovy® (semaglutide 2.4 mg) that highlight its role in enhancing liver health in adults diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), even in the context of limited weight loss. This revelation emerged from a post hoc...

Continue Reading
Free Software Revolutionizing Sustainability in Real Estate

Updated Category News Views 92

Measurabl Introduces Free Sustainability Software Measurabl, renowned for its sustainability data platform in real estate, has unveiled a groundbreaking free software solution. This innovative tool allows property and portfolio managers to measure, manage, and report on sustainability performance without any cost. With this recent launch, Measurabl has already registered...

Continue Reading
The Joint Corp. Achieves Significant Growth in 2024 Metrics

Updated Category News Views 138

The Joint Corp. Showcases Remarkable Growth in 2024 Metrics - Adjustments Performed in 2024 Grows 9%, Compared to 2023 - - Receives Letters of Intent for Majority of Corporate Portfolio - SCOTTSDALE, Ariz. — The Joint Corp. (NASDAQ: JYNT), a leader in chiropractic care across the nation, has reported impressive operating metrics for the year ending 2024. The company's...

Continue Reading